Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)
China · Delayed Price · Currency is CNY 16.89
-0.34 (-1.97%)
Jun 11, 2026, 3:00 PM CST
Shanghai ZJ Bio-Tech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -43.79 | -34.3 | -127.46 | -136.86 | 760.27 | 758.52 |
Depreciation & Amortization | 65.27 | 65.27 | 68.4 | 66.69 | 60.24 | 24.84 |
Other Amortization | 1.83 | 1.83 | 0.72 | 0.59 | 0.08 | - |
Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.04 | - | -0.03 | - |
Asset Writedown & Restructuring Costs | 0.43 | 0.43 | 22.53 | 1.15 | 0.59 | 0.03 |
Loss (Gain) From Sale of Investments | -6.18 | -6.18 | -0.06 | - | - | - |
Provision & Write-off of Bad Debts | 0.39 | 0.39 | 8.41 | 1.36 | 6.35 | 5.38 |
Other Operating Activities | 23.08 | 19.25 | 134.73 | 169.99 | -62.76 | 28.33 |
Change in Accounts Receivable | 27.88 | 27.88 | 37.31 | 114.77 | 12.17 | -25.19 |
Change in Inventory | 10.51 | 10.51 | 36.37 | 31.72 | -297.19 | -172.51 |
Change in Accounts Payable | -10.98 | -10.98 | -81.05 | -304.21 | 104.49 | 16.72 |
Change in Other Net Operating Assets | 0.73 | 0.73 | 0.98 | 0.61 | 1.18 | 5.86 |
Operating Cash Flow | 61.19 | 66.85 | 77.59 | -81.88 | 584.97 | 641.94 |
Operating Cash Flow Growth | -3.34% | -13.84% | - | - | -8.87% | -43.78% |
Capital Expenditures | -21.97 | -1.99 | -19.49 | -81.15 | -74.56 | -498.06 |
Sale of Property, Plant & Equipment | 0.63 | 0.63 | 0.01 | 1.14 | 0.06 | - |
Investment in Securities | -223.28 | -305.36 | 0.06 | 2.32 | -1.53 | -21 |
Investing Cash Flow | -244.63 | -306.72 | -19.42 | -77.69 | -76.02 | -519.06 |
Long-Term Debt Issued | - | 297 | - | - | - | - |
Long-Term Debt Repaid | - | -5.22 | -2.51 | -3.65 | -3.75 | - |
Net Debt Issued (Repaid) | 190.8 | 291.78 | -2.51 | -3.65 | -3.75 | - |
Issuance of Common Stock | - | - | - | - | - | 1,959 |
Repurchase of Common Stock | -259.11 | -259.11 | -35.33 | - | -102.03 | - |
Common Dividends Paid | -4.2 | -3.03 | -20.88 | -230.74 | -265.62 | -311.53 |
Other Financing Activities | 70.33 | - | - | - | - | -19.3 |
Financing Cash Flow | -2.17 | 29.64 | -58.72 | -234.39 | -371.4 | 1,628 |
Foreign Exchange Rate Adjustments | -37.01 | -23.01 | 14.44 | 15.77 | 74.35 | -19.82 |
Net Cash Flow | -222.62 | -233.24 | 13.89 | -378.19 | 211.9 | 1,731 |
Free Cash Flow | 39.22 | 64.86 | 58.1 | -163.03 | 510.41 | 143.88 |
Free Cash Flow Growth | -28.04% | 11.63% | - | - | 254.76% | -86.52% |
Free Cash Flow Margin | 33.21% | 51.96% | 32.52% | -59.43% | 21.94% | 7.13% |
Free Cash Flow Per Share | 0.23 | 0.36 | 0.30 | -0.85 | 2.64 | 0.76 |
Cash Income Tax Paid | - | -12.18 | 17.21 | 52.97 | 188.93 | 261.3 |
Levered Free Cash Flow | 11.52 | 43.15 | 42.13 | -98.85 | 410.82 | -144.71 |
Unlevered Free Cash Flow | 13.7 | 45.33 | 42.35 | -98.63 | 411.11 | -144.71 |
Change in Working Capital | 20.21 | 20.21 | -29.64 | -184.81 | -179.76 | -175.17 |